Norfolk, VA, United States of America

Cythnia E Keppel


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Hadron Treatment Planning by Cythnia E. Keppel

Introduction

Cythnia E. Keppel is a notable inventor based in Norfolk, Virginia. She has made significant contributions to the field of medical treatment planning, particularly in the area of hadron therapy. Her innovative approach focuses on optimizing treatment methods for patients afflicted with various medical conditions.

Latest Patents

Cythnia E. Keppel holds a patent for "Hadron treatment planning with adequate biological weighting." This patent outlines treatment planning methods that determine the variability of relative biological effectiveness (RBE) along a beam line. The methods calculate the intensity of hadron beams, such as proton or carbon ion beams, required to achieve a desired biological dose at the treatment site. The patent details the calculation of three or four RBE values at corresponding spatially-dispersed intervals along the beam line. Specifically, it includes RBE values for the spread-out Bragg peak (SOBP) region, as well as for the proximal and distal sections of the treatment site.

Career Highlights

Cythnia E. Keppel is affiliated with Hampton University, where she continues to advance her research and innovations in hadron therapy. Her work has garnered attention for its potential to improve treatment outcomes for patients undergoing radiation therapy.

Collaborations

Cythnia has collaborated with notable colleagues, including Richard A. Britten and Vahagn R. Nazaryan. These collaborations have contributed to the development and refinement of her innovative treatment planning methods.

Conclusion

Cythnia E. Keppel's contributions to hadron treatment planning represent a significant advancement in medical technology. Her innovative methods have the potential to enhance the effectiveness of cancer treatments, ultimately benefiting patients in need of precise and effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…